These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9223047)

  • 41. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadobenate dimeglumine (BOPTA) enhanced MR imaging: patterns of enhancement in normal liver and cirrhosis.
    Manfredi R; Maresca G; Baron RL; De Franco A; De Gaetano AM; Cotroneo AR; Pirovano G; Spinazzi A; Marano P
    J Magn Reson Imaging; 1998; 8(4):862-7. PubMed ID: 9702888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [NMR tomography of the liver with the new contrast agent Gd-BOPTA. The results of an in-vivo phase-I test].
    Vogl TJ; Pegios W; Waitzinger J; Pirovano G; Balzer J; Lissner J
    Rofo; 1992 May; 156(5):465-70. PubMed ID: 1596551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.
    Bangard C; Stippel DL; Berg F; Kasper HU; Hellmich M; Fischer JH; Hölscher A; Lackner K; Gossmann A
    J Magn Reson Imaging; 2008 Jul; 28(1):263-70. PubMed ID: 18581392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers.
    Planchamp C; Gex-Fabry M; Becker CD; Pastor CM
    Invest Radiol; 2007 Jul; 42(7):513-21. PubMed ID: 17568274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
    Colosimo C; Knopp MV; Barreau X; Gérardin E; Kirchin MA; Guézénoc F; Lodemann KP
    Neuroradiology; 2004 Aug; 46(8):655-65. PubMed ID: 15205859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images.
    Marin D; Iannaccone R; Catalano C; Passariello R
    J Magn Reson Imaging; 2006 Sep; 24(3):690-4. PubMed ID: 16878304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How transfer rates generate Gd-BOPTA concentrations in rat liver compartments: implications for clinical liver imaging with hepatobiliary contrast agents.
    Pastor CM
    Contrast Media Mol Imaging; 2016 Jul; 11(4):291-8. PubMed ID: 27060676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA.
    Planchamp C; Pastor CM; Balant L; Becker CD; Terrier F; Gex-Fabry M
    Invest Radiol; 2005 Nov; 40(11):705-14. PubMed ID: 16230903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dextran magnetite as a liver contrast agent.
    Magin RL; Bacic G; Niesman MR; Alameda JC; Wright SM; Swartz HM
    Magn Reson Med; 1991 Jul; 20(1):1-16. PubMed ID: 1943651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats.
    Kreft BP; Tanimoto A; Stark DD; Baba Y; Zhao L; Chen JT; Compton CC; Finn JP; Cavagna FM
    J Magn Reson Imaging; 1993; 3(1):41-9. PubMed ID: 8428100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
    White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
    Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MR imaging of CNS tumors: are all contrast agents created the same?
    Essig M
    Neuroradiology; 2006 Apr; 48 Suppl 1():3-8. PubMed ID: 16699847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals.
    de Haën C; La Ferla R; Maggioni F
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S169-79. PubMed ID: 10608413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.